Zhitong Finance App News, Sanbo Brain Technology (301293.SZ) announced that the daily closing price increase deviation value of the company's stock exceeded 30% for 2 consecutive trading days on January 5 and January 6, 2026, which is a situation where stock trading fluctuated abnormally. The company is a medical service group that specializes in neurology. Its hospitals mainly provide patients with comprehensive medical services focusing on high-precision neurosurgery. Currently, the company is not involved in R&D, production and sales of brain-computer interface products. Revenue from neuromodulation technology accounts for very little of the company's revenue, and there is basically no impact on the company's performance.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Sanbo Brain Technology (301293.SZ) announced that the daily closing price increase deviation value of the company's stock exceeded 30% for 2 consecutive trading days on January 5 and January 6, 2026, which is a situation where stock trading fluctuated abnormally. The company is a medical service group that specializes in neurology. Its hospitals mainly provide patients with comprehensive medical services focusing on high-precision neurosurgery. Currently, the company is not involved in R&D, production and sales of brain-computer interface products. Revenue from neuromodulation technology accounts for very little of the company's revenue, and there is basically no impact on the company's performance.